TOI · Categories · Form 4

TOI - SEC Form 4 insider transactions

The Oncology Institute Inc. (TOI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TOI

• 1d
  Director Hively Brad sold $1,946,310 worth of shares (298,853 units at $6.51), decreasing direct ownership by 42% to 411,976 units (SEC Form 4)

  4 - Starling Oncology, Inc. (0001799191) (Issuer)
• 27d
  Director Kaushal Mohit was granted 33,133 shares, increasing direct ownership by 19% to 205,716 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Mcgeorge Anne was granted 41,165 shares, increasing direct ownership by 14% to 332,535 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Pacala Mark L was granted 30,120 shares, increasing direct ownership by 12% to 286,881 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Stolper Mark was granted 31,124 shares, increasing direct ownership by 120% to 56,957 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Tzoumakas Kimberly Jo was granted 29,116 shares, increasing direct ownership by 169% to 46,301 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Hively Brad was granted 27,108 shares, increasing direct ownership by 4% to 710,829 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 27d
  Director Johnson Karen Marie was granted 31,124 shares, increasing direct ownership by 11% to 319,410 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 40d
  Chief Medical Officer Podnos Yale exercised 23,452 shares at a strike of $1.90 and sold $150,340 worth of shares (23,452 units at $6.41) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 47d
  Director Tzoumakas Kimberly Jo was granted 17,185 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 47d
  Director Stolper Mark was granted 25,833 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 77d
  Chief Medical Officer Podnos Yale sold $126,094 worth of shares (23,451 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 259,527 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 95d
  Chief Medical Officer Podnos Yale disposed of $8,068 worth of shares (1,805 units at $4.47), decreasing direct ownership by 0.63% to 282,978 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 95d
  Chief Executive Officer Virnich Daniel disposed of $103,069 worth of shares (23,058 units at $4.47), decreasing direct ownership by 0.98% to 2,337,166 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 95d
  Chief Financial Officer Carter Robert Ross disposed of $7,170 worth of shares (1,604 units at $4.47), decreasing direct ownership by 0.39% to 414,801 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 124d
  SEC Form 4 filed by Chief Administrative Officer England Kristin

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 124d
  SEC Form 4 filed by Chief Clinical Officer Langsam Jeffrey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 131d
  SEC Form 4 filed by Kaushal Mohit

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 134d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 146d
  SEC Form 4 filed by Langsam Jeffrey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 146d
  SEC Form 4 filed by England Kristin

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 146d
  SEC Form 4 filed by Podnos Yale

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 146d
  SEC Form 4 filed by Carter Robert Ross

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 146d
  SEC Form 4 filed by Virnich Daniel

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 148d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 151d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 153d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 155d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 160d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 160d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 160d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 231d
  Amendment: Chief Financial Officer Carter Robert Ross disposed of $895 worth of shares (244 units at $3.67), decreasing direct ownership by 0.10% to 235,125 units (SEC Form 4)

  4/A - Oncology Institute, Inc. (0001799191) (Issuer)
• 232d
  Chief Financial Officer Carter Robert Ross sold $879 worth of shares (247 units at $3.56), decreasing direct ownership by 0.10% to 235,122 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 252d
  Director Hively Brad sold $50,291 worth of shares (13,333 units at $3.77), decreasing direct ownership by 2% to 683,721 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 267d
  SEC Form 4 filed by Director Ling Gabriel

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Mcgeorge Anne was granted 108,024 shares, increasing direct ownership by 59% to 291,370 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Kaushal Mohit was granted 91,049 shares, increasing direct ownership by 51% to 268,302 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Ling Gabriel was granted 83,333 shares, increasing direct ownership by 33% to 333,539 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Johnson Karen Marie was granted 84,877 shares, increasing direct ownership by 42% to 288,286 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Pacala Mark L was granted 81,790 shares, increasing direct ownership by 47% to 256,761 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 274d
  Director Hively Brad was granted 74,074 shares, increasing direct ownership by 12% to 697,054 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 278d
  Director Pacala Mark L sold $200,000 worth of shares (50,000 units at $4.00), decreasing direct ownership by 22% to 174,971 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 278d
  Director M33 Growth I L.P. disposed of 3,090,892 shares and acquired 11,818 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 278d
  Director Ling Gabriel acquired 141,149 shares, increasing direct ownership by 129% to 250,206 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 279d
  Chief Executive Officer Virnich Daniel was granted 6,464 shares, increasing direct ownership by 0.36% to 1,799,984 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 279d
  Chief Medical Officer Podnos Yale was granted 2,086 shares, increasing direct ownership by 0.88% to 237,930 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 279d
  Chief Financial Officer Carter Robert Ross was granted 195 shares, increasing direct ownership by 0.08% to 235,369 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 284d
  Chief Medical Officer Podnos Yale was granted 1,508 shares, increasing direct ownership by 0.64% to 235,844 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 284d
  Chief Executive Officer Virnich Daniel was granted 6,211 shares, increasing direct ownership by 0.35% to 1,793,520 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 354d
  Director M33 Growth I L.P. sold $20,703,000 worth of shares (6,700,000 units at $3.09) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 369d
  Director Hively Brad sold $82,097 worth of shares (20,221 units at $4.06), decreasing direct ownership by 3% to 622,980 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 376d
  SEC Form 4 filed by Director Barasch Richard A

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 393d
  Director Barasch Richard A disposed of 287,756 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 397d
  Chief Administrative Officer England Kristin was granted 98,037 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 427d
  Director Barasch Richard A exercised 679,224 in-the-money shares at a strike of $1.20 and covered exercise/tax liability with 311,128 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 431d
  Director Barasch Richard A converted options into 779,900 shares, increasing direct ownership by 9% to 1,935,141 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 442d
  Director M33 Growth I L.P. sold $2,287,500 worth of shares (750,000 units at $3.05) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 446d
  Director Hively Brad exercised 1,867,605 shares at a strike of $0.90 and sold $5,672,106 worth of shares (1,976,137 units at $2.87), decreasing direct ownership by 15% to 603,501 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 459d
  Chief Clinical Officer Langsam Jeffrey was granted 57,380 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 460d
  Director M33 Growth I L.P. sold $5,425,800 worth of shares (2,000,000 units at $2.71) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)

Other TOI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends